| 0 |
VASCULAR ANASTOMOTIC HAEMORRHAGE |
23 |
0.7667 |
| 1 |
NEW ONSET DIABETES AFTER TRANSPLANTATION |
52 |
0.3006 |
| 2 |
CENTRAL NERVOUS SYSTEM LUPUS |
58 |
0.2601 |
| 3 |
MALACOPLAKIA |
112 |
0.2445 |
| 4 |
URINOMA |
33 |
0.2089 |
| 5 |
DELAYED GRAFT FUNCTION |
134 |
0.1885 |
| 6 |
BACILLARY ANGIOMATOSIS |
25 |
0.1838 |
| 7 |
DISSEMINATED NOCARDIOSIS |
24 |
0.1727 |
| 8 |
PANCREAS TRANSPLANT REJECTION |
34 |
0.1692 |
| 9 |
DONOR SPECIFIC ANTIBODY PRESENT |
26 |
0.1688 |
| 10 |
HEART FAILURE WITH PRESERVED EJECTION FRACTION |
49 |
0.1667 |
| 11 |
RHODOCOCCUS INFECTION |
27 |
0.1627 |
| 12 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
366 |
0.1612 |
| 13 |
CEREBRAL NOCARDIOSIS |
37 |
0.1588 |
| 14 |
CHRONIC ALLOGRAFT NEPHROPATHY |
122 |
0.1558 |
| 15 |
BODY MASS INDEX ABNORMAL |
38 |
0.1557 |
| 16 |
KIDNEY TRANSPLANT REJECTION |
716 |
0.1491 |
| 17 |
APOPTOSIS |
44 |
0.1424 |
| 18 |
C3 GLOMERULOPATHY |
28 |
0.1353 |
| 19 |
HUMAN EHRLICHIOSIS |
28 |
0.1340 |
| 20 |
RENAL TRANSPLANT FAILURE |
132 |
0.1336 |
| 21 |
RENAL CYST HAEMORRHAGE |
30 |
0.1327 |
| 22 |
DISSEMINATED MUCORMYCOSIS |
52 |
0.1320 |
| 23 |
TRICHODYSPLASIA SPINULOSA |
50 |
0.1312 |
| 24 |
MONKEYPOX |
36 |
0.1304 |
| 25 |
PULMONARY NOCARDIOSIS |
105 |
0.1274 |
| 26 |
POLYOMAVIRUS VIRAEMIA |
134 |
0.1262 |
| 27 |
AMAUROSIS FUGAX |
134 |
0.1244 |
| 28 |
DISSEMINATED CRYPTOCOCCOSIS |
94 |
0.1242 |
| 29 |
LYMPHOCELE |
82 |
0.1235 |
| 30 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
285 |
0.1215 |
| 31 |
CRYPTOCOCCAL CUTANEOUS INFECTION |
22 |
0.1209 |
| 32 |
WEST NILE VIRAL INFECTION |
89 |
0.1187 |
| 33 |
RENAL-LIMITED THROMBOTIC MICROANGIOPATHY |
27 |
0.1174 |
| 34 |
BLASTOMYCOSIS |
54 |
0.1111 |
| 35 |
RENAL GRAFT INFECTION |
25 |
0.1078 |
| 36 |
DISSEMINATED STRONGYLOIDIASIS |
22 |
0.1005 |
| 37 |
TRANSPLANT DYSFUNCTION |
177 |
0.0991 |
| 38 |
PHAEOHYPHOMYCOSIS |
45 |
0.0939 |
| 39 |
TRANSPLANT REJECTION |
745 |
0.0929 |
| 40 |
PARVOVIRUS B19 INFECTION |
83 |
0.0927 |
| 41 |
RENAL TUBULAR ATROPHY |
81 |
0.0918 |
| 42 |
HERPES SIMPLEX HEPATITIS |
22 |
0.0917 |
| 43 |
CAT SCRATCH DISEASE |
36 |
0.0896 |
| 44 |
CRYPTOCOCCOSIS |
142 |
0.0871 |
| 45 |
ALTERNARIA INFECTION |
32 |
0.0860 |
| 46 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
426 |
0.0836 |
| 47 |
HUMAN POLYOMAVIRUS INFECTION |
42 |
0.0791 |
| 48 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
260 |
0.0786 |
| 49 |
BK VIRUS INFECTION |
261 |
0.0773 |
| 50 |
SEROSITIS |
42 |
0.0759 |
| 51 |
KIDNEY FIBROSIS |
129 |
0.0743 |
| 52 |
CRYPTOSPORIDIOSIS INFECTION |
39 |
0.0743 |
| 53 |
HEART TRANSPLANT REJECTION |
77 |
0.0742 |
| 54 |
CYTOMEGALOVIRUS OESOPHAGITIS |
27 |
0.0734 |
| 55 |
VASCULAR COMPRESSION |
23 |
0.0728 |
| 56 |
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM |
22 |
0.0726 |
| 57 |
PULMONARY MUCORMYCOSIS |
38 |
0.0720 |
| 58 |
CYSTITIS VIRAL |
27 |
0.0705 |
| 59 |
TRANSPLANTATION COMPLICATION |
29 |
0.0690 |
| 60 |
INFECTION REACTIVATION |
78 |
0.0681 |
| 61 |
LUPUS NEPHRITIS |
125 |
0.0668 |
| 62 |
PNEUMONIA CRYPTOCOCCAL |
63 |
0.0667 |
| 63 |
UREAPLASMA INFECTION |
27 |
0.0662 |
| 64 |
NOCARDIOSIS |
165 |
0.0645 |
| 65 |
DOUBLE STRANDED DNA ANTIBODY POSITIVE |
21 |
0.0644 |
| 66 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
103 |
0.0643 |
| 67 |
CYTOMEGALOVIRUS VIRAEMIA |
286 |
0.0642 |
| 68 |
SCEDOSPORIUM INFECTION |
45 |
0.0637 |
| 69 |
GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE |
33 |
0.0630 |
| 70 |
LUNG TRANSPLANT REJECTION |
41 |
0.0621 |
| 71 |
HEPATITIS E |
96 |
0.0608 |
| 72 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
22 |
0.0604 |
| 73 |
HISTOPLASMOSIS DISSEMINATED |
93 |
0.0586 |
| 74 |
INCISION SITE PAIN |
68 |
0.0578 |
| 75 |
EPSTEIN-BARR VIRAEMIA |
64 |
0.0577 |
| 76 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
69 |
0.0575 |
| 77 |
JC VIRUS INFECTION |
91 |
0.0569 |
| 78 |
LIVER TRANSPLANT REJECTION |
101 |
0.0562 |
| 79 |
TRANSPLANT FAILURE |
131 |
0.0534 |
| 80 |
GRAFT LOSS |
38 |
0.0524 |
| 81 |
GRAFT VERSUS HOST DISEASE IN LUNG |
25 |
0.0523 |
| 82 |
CYTOMEGALOVIRUS INFECTION |
831 |
0.0499 |
| 83 |
ANGIOSARCOMA |
23 |
0.0499 |
| 84 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA |
29 |
0.0491 |
| 85 |
MENINGITIS CRYPTOCOCCAL |
85 |
0.0486 |
| 86 |
STRONGYLOIDIASIS |
78 |
0.0482 |
| 87 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
102 |
0.0479 |
| 88 |
RENAL ARTERY STENOSIS |
66 |
0.0479 |
| 89 |
RED BLOOD CELLS URINE POSITIVE |
46 |
0.0476 |
| 90 |
GRAFT VERSUS HOST DISEASE IN LIVER |
34 |
0.0475 |
| 91 |
GLOMERULOSCLEROSIS |
30 |
0.0475 |
| 92 |
CYTOMEGALOVIRUS COLITIS |
109 |
0.0474 |
| 93 |
URETERIC STENOSIS |
37 |
0.0462 |
| 94 |
GRAFT COMPLICATION |
27 |
0.0460 |
| 95 |
VISCERAL LEISHMANIASIS |
32 |
0.0443 |
| 96 |
GRAFT VERSUS HOST DISEASE IN SKIN |
95 |
0.0431 |
| 97 |
BRAIN ABSCESS |
107 |
0.0422 |
| 98 |
ALVEOLAR PROTEINOSIS |
25 |
0.0422 |
| 99 |
MUCORMYCOSIS |
109 |
0.0419 |
| 100 |
COMPLICATIONS OF TRANSPLANT SURGERY |
21 |
0.0416 |
| 101 |
CEREBRAL TOXOPLASMOSIS |
38 |
0.0407 |
| 102 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
29 |
0.0404 |
| 103 |
RENAL TUBULAR INJURY |
48 |
0.0395 |
| 104 |
ENTEROCOCCAL INFECTION |
185 |
0.0382 |
| 105 |
VARICELLA ZOSTER VIRUS INFECTION |
78 |
0.0376 |
| 106 |
HUMAN HERPESVIRUS 8 INFECTION |
22 |
0.0361 |
| 107 |
RENAL TRANSPLANT |
130 |
0.0360 |
| 108 |
VIRAEMIA |
49 |
0.0354 |
| 109 |
ENCEPHALITIS VIRAL |
42 |
0.0345 |
| 110 |
CEREBRAL ASPERGILLOSIS |
21 |
0.0341 |
| 111 |
HISTOPLASMOSIS |
60 |
0.0339 |
| 112 |
ATYPICAL HAEMOLYTIC URAEMIC SYNDROME |
27 |
0.0332 |
| 113 |
PNEUMONIA CYTOMEGALOVIRAL |
64 |
0.0329 |
| 114 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
46 |
0.0326 |
| 115 |
ANOGENITAL WARTS |
29 |
0.0325 |
| 116 |
INTERVERTEBRAL DISC SPACE NARROWING |
26 |
0.0323 |
| 117 |
KLEBSIELLA INFECTION |
163 |
0.0322 |
| 118 |
EPSTEIN-BARR VIRUS INFECTION |
198 |
0.0317 |
| 119 |
URINARY TRACT DISORDER |
142 |
0.0315 |
| 120 |
ENTEROBACTER INFECTION |
52 |
0.0309 |
| 121 |
HUMAN HERPESVIRUS 6 INFECTION |
58 |
0.0307 |
| 122 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
42 |
0.0305 |
| 123 |
ASPERGILLUS INFECTION |
200 |
0.0304 |
| 124 |
SUPERINFECTION BACTERIAL |
24 |
0.0303 |
| 125 |
ACINETOBACTER INFECTION |
33 |
0.0301 |
| 126 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
53 |
0.0300 |
| 127 |
CAROTID ARTERIOSCLEROSIS |
30 |
0.0291 |
| 128 |
BRONCHOPULMONARY ASPERGILLOSIS |
225 |
0.0290 |
| 129 |
THROMBOTIC MICROANGIOPATHY |
281 |
0.0288 |
| 130 |
AORTIC DILATATION |
32 |
0.0288 |
| 131 |
GASTROENTERITIS NOROVIRUS |
38 |
0.0286 |
| 132 |
ADENOVIRUS INFECTION |
83 |
0.0286 |
| 133 |
IGA NEPHROPATHY |
47 |
0.0283 |
| 134 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
37 |
0.0281 |
| 135 |
PNEUMONIA PSEUDOMONAL |
43 |
0.0280 |
| 136 |
PAPILLOMA VIRAL INFECTION |
46 |
0.0279 |
| 137 |
ENTEROVIRUS INFECTION |
24 |
0.0278 |
| 138 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
25 |
0.0270 |
| 139 |
TRANSITIONAL CELL CARCINOMA |
35 |
0.0270 |
| 140 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
202 |
0.0269 |
| 141 |
DISSEMINATED TUBERCULOSIS |
69 |
0.0269 |
| 142 |
HYPERPARATHYROIDISM SECONDARY |
67 |
0.0267 |
| 143 |
NOROVIRUS INFECTION |
38 |
0.0263 |
| 144 |
KLEBSIELLA BACTERAEMIA |
25 |
0.0263 |
| 145 |
DRUG LEVEL FLUCTUATING |
23 |
0.0259 |
| 146 |
PSEUDOMONAL BACTERAEMIA |
22 |
0.0258 |
| 147 |
RECTAL PROLAPSE |
31 |
0.0257 |
| 148 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
27 |
0.0254 |
| 149 |
OBLITERATIVE BRONCHIOLITIS |
33 |
0.0251 |
| 150 |
SECONDARY IMMUNODEFICIENCY |
30 |
0.0247 |
| 151 |
PYELONEPHRITIS ACUTE |
48 |
0.0245 |
| 152 |
TOXOPLASMOSIS |
26 |
0.0241 |
| 153 |
BUTTERFLY RASH |
24 |
0.0237 |
| 154 |
APLASIA PURE RED CELL |
81 |
0.0235 |
| 155 |
LISTERIOSIS |
26 |
0.0235 |
| 156 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
103 |
0.0233 |
| 157 |
KLEBSIELLA SEPSIS |
26 |
0.0231 |
| 158 |
VACCINATION FAILURE |
38 |
0.0228 |
| 159 |
PNEUMONIA KLEBSIELLA |
41 |
0.0223 |
| 160 |
PSEUDOMONAS INFECTION |
190 |
0.0221 |
| 161 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
60 |
0.0217 |
| 162 |
SYSTEMIC MYCOSIS |
25 |
0.0214 |
| 163 |
CHRONIC GRAFT VERSUS HOST DISEASE |
77 |
0.0213 |
| 164 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
214 |
0.0213 |
| 165 |
ESCHERICHIA INFECTION |
175 |
0.0213 |
| 166 |
GLOMERULONEPHRITIS |
52 |
0.0212 |
| 167 |
PROTEIN URINE PRESENT |
105 |
0.0210 |
| 168 |
ESCHERICHIA URINARY TRACT INFECTION |
88 |
0.0207 |
| 169 |
STENOTROPHOMONAS INFECTION |
28 |
0.0206 |
| 170 |
HAEMORRHAGIC STROKE |
160 |
0.0205 |
| 171 |
HAEMOLYTIC URAEMIC SYNDROME |
47 |
0.0203 |
| 172 |
ACUTE GRAFT VERSUS HOST DISEASE |
92 |
0.0201 |
| 173 |
CYTOMEGALOVIRUS TEST POSITIVE |
35 |
0.0196 |
| 174 |
RENAL TUBULAR NECROSIS |
191 |
0.0195 |
| 175 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
184 |
0.0193 |
| 176 |
GINGIVAL HYPERTROPHY |
29 |
0.0191 |
| 177 |
CYSTITIS HAEMORRHAGIC |
77 |
0.0191 |
| 178 |
NEPHROPATHY TOXIC |
213 |
0.0190 |
| 179 |
MYCOBACTERIAL INFECTION |
32 |
0.0186 |
| 180 |
HYPERPARATHYROIDISM |
38 |
0.0184 |
| 181 |
ESCHERICHIA BACTERAEMIA |
43 |
0.0183 |
| 182 |
DIFFUSE ALVEOLAR DAMAGE |
21 |
0.0183 |
| 183 |
PNEUMONIA FUNGAL |
72 |
0.0182 |
| 184 |
HYDRONEPHROSIS |
136 |
0.0181 |
| 185 |
ACTINIC KERATOSIS |
47 |
0.0181 |
| 186 |
SQUAMOUS CELL CARCINOMA OF SKIN |
109 |
0.0180 |
| 187 |
PROTEINURIA |
342 |
0.0180 |
| 188 |
CYTOMEGALOVIRUS CHORIORETINITIS |
35 |
0.0179 |
| 189 |
LARGE INTESTINE INFECTION |
22 |
0.0179 |
| 190 |
OESOPHAGEAL ULCER |
67 |
0.0174 |
| 191 |
B-CELL LYMPHOMA |
59 |
0.0174 |
| 192 |
DISTRIBUTIVE SHOCK |
39 |
0.0172 |
| 193 |
URINARY TRACT INFECTION BACTERIAL |
43 |
0.0170 |
| 194 |
PYELONEPHRITIS |
147 |
0.0169 |
| 195 |
CALCIPHYLAXIS |
31 |
0.0169 |
| 196 |
PNEUMONIA LEGIONELLA |
27 |
0.0169 |
| 197 |
HYPOGAMMAGLOBULINAEMIA |
109 |
0.0166 |
| 198 |
INFECTIOUS PLEURAL EFFUSION |
25 |
0.0164 |
| 199 |
GRAFT VERSUS HOST DISEASE |
116 |
0.0161 |
| 200 |
HAEMATOLOGICAL INFECTION |
38 |
0.0155 |
| 201 |
ESCHERICHIA SEPSIS |
45 |
0.0155 |
| 202 |
COVID-19 PNEUMONIA |
179 |
0.0151 |
| 203 |
SYSTEMIC INFECTION |
25 |
0.0151 |
| 204 |
GENERALISED OEDEMA |
185 |
0.0149 |
| 205 |
HYPOALBUMINAEMIA |
115 |
0.0148 |
| 206 |
NEPHROGENIC ANAEMIA |
68 |
0.0147 |
| 207 |
STEROID DIABETES |
22 |
0.0147 |
| 208 |
PNEUMOPERITONEUM |
27 |
0.0146 |
| 209 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
72 |
0.0144 |
| 210 |
UROSEPSIS |
133 |
0.0144 |
| 211 |
SALMONELLOSIS |
24 |
0.0142 |
| 212 |
DRUG LEVEL INCREASED |
235 |
0.0142 |
| 213 |
DIFFUSE LARGE B-CELL LYMPHOMA |
109 |
0.0141 |
| 214 |
CONCOMITANT DISEASE PROGRESSION |
27 |
0.0138 |
| 215 |
BACTERIAL SEPSIS |
45 |
0.0138 |
| 216 |
BLOOD CREATININE INCREASED |
892 |
0.0136 |
| 217 |
HEPATOSPLENOMEGALY |
35 |
0.0136 |
| 218 |
BLOOD CREATININE ABNORMAL |
47 |
0.0136 |
| 219 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
111 |
0.0134 |
| 220 |
PNEUMOMEDIASTINUM |
24 |
0.0133 |
| 221 |
OCULAR DISCOMFORT |
148 |
0.0132 |
| 222 |
CUSHINGOID |
42 |
0.0131 |
| 223 |
ELECTROLYTE IMBALANCE |
152 |
0.0131 |
| 224 |
HERPES SIMPLEX |
85 |
0.0131 |
| 225 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
369 |
0.0130 |
| 226 |
EMPYEMA |
25 |
0.0126 |
| 227 |
OESOPHAGEAL STENOSIS |
35 |
0.0123 |
| 228 |
OESOPHAGEAL CANDIDIASIS |
49 |
0.0123 |
| 229 |
NEPHROTIC SYNDROME |
84 |
0.0122 |
| 230 |
LEUKOPENIA |
609 |
0.0122 |
| 231 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
215 |
0.0121 |
| 232 |
MEAN CELL VOLUME INCREASED |
31 |
0.0121 |
| 233 |
RHINOVIRUS INFECTION |
47 |
0.0121 |
| 234 |
AORTIC ARTERIOSCLEROSIS |
31 |
0.0120 |
| 235 |
LARGE INTESTINAL ULCER |
32 |
0.0118 |
| 236 |
END STAGE RENAL DISEASE |
212 |
0.0116 |
| 237 |
DRUG LEVEL ABOVE THERAPEUTIC |
52 |
0.0113 |
| 238 |
HYPERVOLAEMIA |
55 |
0.0111 |
| 239 |
BLOOD UREA INCREASED |
186 |
0.0111 |
| 240 |
LUNG CONSOLIDATION |
31 |
0.0111 |
| 241 |
NEUTROPHIL COUNT INCREASED |
112 |
0.0109 |
| 242 |
SEPTIC SHOCK |
470 |
0.0108 |
| 243 |
DUODENITIS |
33 |
0.0107 |
| 244 |
SCLERODERMA |
39 |
0.0107 |
| 245 |
RENAL TUBULAR ACIDOSIS |
23 |
0.0105 |
| 246 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
28 |
0.0105 |
| 247 |
GRANULOMA |
36 |
0.0104 |
| 248 |
BACTERAEMIA |
123 |
0.0104 |
| 249 |
PNEUMONIA VIRAL |
33 |
0.0103 |
| 250 |
ORGANISING PNEUMONIA |
51 |
0.0103 |
| 251 |
ENCEPHALITIS |
71 |
0.0103 |
| 252 |
DYSLIPIDAEMIA |
51 |
0.0100 |
| 253 |
AZOTAEMIA |
40 |
0.0100 |
| 254 |
PULMONARY ALVEOLAR HAEMORRHAGE |
56 |
0.0100 |
| 255 |
HEPATIC FIBROSIS |
34 |
0.0099 |
| 256 |
DERMATOMYOSITIS |
25 |
0.0099 |
| 257 |
HYPERURICAEMIA |
40 |
0.0097 |
| 258 |
LYMPHOPENIA |
137 |
0.0097 |
| 259 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
26 |
0.0097 |
| 260 |
LIVER TRANSPLANT |
35 |
0.0096 |
| 261 |
LEFT VENTRICULAR HYPERTROPHY |
41 |
0.0096 |
| 262 |
SYSTEMIC CANDIDA |
24 |
0.0096 |
| 263 |
PNEUMATOSIS INTESTINALIS |
27 |
0.0095 |
| 264 |
ACUTE RESPIRATORY FAILURE |
182 |
0.0095 |
| 265 |
PATHOGEN RESISTANCE |
86 |
0.0094 |
| 266 |
BILIRUBIN CONJUGATED INCREASED |
22 |
0.0094 |
| 267 |
NEPHROPATHY |
87 |
0.0093 |
| 268 |
HAEMATURIA |
316 |
0.0092 |
| 269 |
GLOMERULAR FILTRATION RATE DECREASED |
113 |
0.0092 |
| 270 |
CANDIDA INFECTION |
155 |
0.0092 |
| 271 |
ENDOCARDITIS |
47 |
0.0092 |
| 272 |
URINE OUTPUT DECREASED |
80 |
0.0091 |
| 273 |
CLOSTRIDIUM DIFFICILE COLITIS |
97 |
0.0091 |
| 274 |
DIVERTICULUM INTESTINAL |
40 |
0.0091 |
| 275 |
BENIGN PROSTATIC HYPERPLASIA |
47 |
0.0091 |
| 276 |
BRAIN HERNIATION |
27 |
0.0090 |
| 277 |
OLIGURIA |
56 |
0.0090 |
| 278 |
RENAL IMPAIRMENT |
752 |
0.0089 |
| 279 |
SQUAMOUS CELL CARCINOMA |
84 |
0.0089 |
| 280 |
LYMPHOCYTE COUNT DECREASED |
156 |
0.0088 |
| 281 |
ACUTE KIDNEY INJURY |
1344 |
0.0088 |
| 282 |
LUNG TRANSPLANT |
31 |
0.0087 |
| 283 |
HEAD DISCOMFORT |
155 |
0.0087 |
| 284 |
POSTOPERATIVE WOUND INFECTION |
59 |
0.0087 |
| 285 |
VENOOCCLUSIVE LIVER DISEASE |
43 |
0.0087 |
| 286 |
MYASTHENIA GRAVIS |
70 |
0.0087 |
| 287 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
33 |
0.0086 |
| 288 |
WOUND DEHISCENCE |
29 |
0.0086 |
| 289 |
LYMPHOPROLIFERATIVE DISORDER |
25 |
0.0085 |
| 290 |
BLOOD IMMUNOGLOBULIN G DECREASED |
21 |
0.0085 |
| 291 |
URINE ANALYSIS ABNORMAL |
25 |
0.0084 |
| 292 |
PHOTOPHOBIA |
155 |
0.0082 |
| 293 |
ABDOMINAL INFECTION |
21 |
0.0082 |
| 294 |
BONE EROSION |
29 |
0.0082 |
| 295 |
ASCITES |
241 |
0.0082 |
| 296 |
HEPATITIS B REACTIVATION |
26 |
0.0082 |
| 297 |
FIBROSIS |
25 |
0.0081 |
| 298 |
SPINAL STENOSIS |
33 |
0.0080 |
| 299 |
TUBULOINTERSTITIAL NEPHRITIS |
149 |
0.0079 |
| 300 |
CHOLANGITIS |
49 |
0.0079 |
| 301 |
STAPHYLOCOCCAL BACTERAEMIA |
34 |
0.0078 |
| 302 |
BLOOD ALBUMIN DECREASED |
62 |
0.0078 |
| 303 |
NEPHRITIS |
26 |
0.0078 |
| 304 |
HISTIOCYTOSIS HAEMATOPHAGIC |
23 |
0.0077 |
| 305 |
BRONCHIECTASIS |
52 |
0.0077 |
| 306 |
BLOOD CREATINE INCREASED |
34 |
0.0077 |
| 307 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
27 |
0.0077 |
| 308 |
ALTERED STATE OF CONSCIOUSNESS |
166 |
0.0077 |
| 309 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
23 |
0.0076 |
| 310 |
NEPHROGENIC SYSTEMIC FIBROSIS |
23 |
0.0076 |
| 311 |
PRESYNCOPE |
182 |
0.0075 |
| 312 |
HEPATIC NECROSIS |
28 |
0.0074 |
| 313 |
FUNGAL SKIN INFECTION |
30 |
0.0074 |
| 314 |
LIVER ABSCESS |
24 |
0.0074 |
| 315 |
NECROTISING FASCIITIS |
26 |
0.0074 |
| 316 |
CARDIAC FAILURE ACUTE |
49 |
0.0073 |
| 317 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
25 |
0.0073 |
| 318 |
URINE ABNORMALITY |
33 |
0.0073 |
| 319 |
PROSTATITIS |
22 |
0.0072 |
| 320 |
HYPERKALAEMIA |
252 |
0.0072 |
| 321 |
ARTERIOSCLEROSIS |
67 |
0.0071 |
| 322 |
BLOOD URIC ACID INCREASED |
41 |
0.0071 |
| 323 |
HAEMODYNAMIC INSTABILITY |
54 |
0.0071 |
| 324 |
HYPOPHOSPHATAEMIA |
52 |
0.0070 |
| 325 |
GASTROENTERITIS |
102 |
0.0070 |
| 326 |
METABOLIC ACIDOSIS |
221 |
0.0069 |
| 327 |
INTESTINAL ISCHAEMIA |
38 |
0.0069 |
| 328 |
RESPIRATORY FAILURE |
501 |
0.0069 |
| 329 |
BASAL CELL CARCINOMA |
107 |
0.0069 |
| 330 |
HYPOVOLAEMIA |
40 |
0.0068 |
| 331 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
242 |
0.0068 |
| 332 |
HAEMOLYTIC ANAEMIA |
61 |
0.0068 |
| 333 |
IMMUNOSUPPRESSION |
60 |
0.0068 |
| 334 |
MYOSITIS |
61 |
0.0068 |
| 335 |
AGRANULOCYTOSIS |
126 |
0.0068 |
| 336 |
RENAL FAILURE CHRONIC |
52 |
0.0068 |
| 337 |
SKIN NECROSIS |
35 |
0.0067 |
| 338 |
ENCEPHALOPATHY |
165 |
0.0067 |
| 339 |
HAEMATEMESIS |
169 |
0.0067 |
| 340 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
23 |
0.0066 |
| 341 |
BACTERIAL INFECTION |
124 |
0.0066 |
| 342 |
PAPILLOEDEMA |
30 |
0.0066 |
| 343 |
INTRACRANIAL PRESSURE INCREASED |
37 |
0.0066 |
| 344 |
ANURIA |
57 |
0.0066 |
| 345 |
SEPSIS |
738 |
0.0066 |
| 346 |
HERPES VIRUS INFECTION |
38 |
0.0066 |
| 347 |
DIPLOPIA |
171 |
0.0066 |
| 348 |
AORTIC VALVE INCOMPETENCE |
28 |
0.0066 |
| 349 |
ARTHRITIS BACTERIAL |
27 |
0.0066 |
| 350 |
ENTERITIS |
42 |
0.0066 |
| 351 |
ABDOMINAL ABSCESS |
29 |
0.0066 |
| 352 |
SKIN PAPILLOMA |
26 |
0.0065 |
| 353 |
BLINDNESS |
259 |
0.0063 |
| 354 |
HYPERCALCAEMIA |
78 |
0.0063 |
| 355 |
DRUG LEVEL DECREASED |
64 |
0.0063 |
| 356 |
PANCYTOPENIA |
346 |
0.0062 |
| 357 |
SHOCK HAEMORRHAGIC |
50 |
0.0061 |
| 358 |
PNEUMONIA BACTERIAL |
56 |
0.0061 |
| 359 |
RENAL FUNCTION TEST ABNORMAL |
28 |
0.0060 |
| 360 |
COVID-19 |
1057 |
0.0060 |
| 361 |
ATELECTASIS |
58 |
0.0060 |
| 362 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
30 |
0.0059 |
| 363 |
LEUKOCYTOSIS |
107 |
0.0059 |
| 364 |
CORONAVIRUS INFECTION |
39 |
0.0059 |
| 365 |
ACIDOSIS |
45 |
0.0059 |
| 366 |
NEUROTOXICITY |
102 |
0.0058 |
| 367 |
HEPATITIS CHOLESTATIC |
35 |
0.0058 |
| 368 |
LUNG INFECTION |
90 |
0.0058 |
| 369 |
PULMONARY MASS |
86 |
0.0058 |
| 370 |
APLASTIC ANAEMIA |
30 |
0.0057 |
| 371 |
DRUG INTERACTION |
905 |
0.0057 |
| 372 |
ACUTE PULMONARY OEDEMA |
32 |
0.0057 |
| 373 |
RENAL CYST |
45 |
0.0057 |
| 374 |
LARGE INTESTINE POLYP |
39 |
0.0056 |
| 375 |
POLYURIA |
46 |
0.0056 |
| 376 |
C-REACTIVE PROTEIN INCREASED |
204 |
0.0056 |
| 377 |
WOUND INFECTION |
61 |
0.0056 |
| 378 |
LARGE INTESTINE PERFORATION |
38 |
0.0055 |
| 379 |
HYPERTRIGLYCERIDAEMIA |
32 |
0.0055 |
| 380 |
MOUTH ULCERATION |
115 |
0.0055 |
| 381 |
MYOPATHY |
47 |
0.0054 |
| 382 |
HYPOVOLAEMIC SHOCK |
26 |
0.0054 |
| 383 |
GUILLAIN-BARRE SYNDROME |
26 |
0.0054 |
| 384 |
CYTOPENIA |
65 |
0.0053 |
| 385 |
GOUT |
95 |
0.0053 |
| 386 |
STAPHYLOCOCCAL SEPSIS |
26 |
0.0053 |
| 387 |
PULSELESS ELECTRICAL ACTIVITY |
22 |
0.0053 |
| 388 |
HYPOMAGNESAEMIA |
73 |
0.0052 |
| 389 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
58 |
0.0052 |
| 390 |
MENINGITIS |
35 |
0.0052 |
| 391 |
BLOOD POTASSIUM INCREASED |
85 |
0.0052 |
| 392 |
HEPATIC ENZYME ABNORMAL |
26 |
0.0052 |
| 393 |
METASTASES TO LYMPH NODES |
35 |
0.0052 |
| 394 |
DRUG RESISTANCE |
133 |
0.0052 |
| 395 |
HYPERTRANSAMINASAEMIA |
36 |
0.0052 |
| 396 |
COMA |
246 |
0.0052 |
| 397 |
PURULENT DISCHARGE |
22 |
0.0051 |
| 398 |
HEPATOCELLULAR CARCINOMA |
39 |
0.0051 |
| 399 |
DISEASE RECURRENCE |
243 |
0.0051 |
| 400 |
FOOD POISONING |
27 |
0.0050 |
| 401 |
PEMPHIGOID |
38 |
0.0050 |
| 402 |
ODYNOPHAGIA |
30 |
0.0050 |
| 403 |
PULMONARY FUNCTION TEST DECREASED |
22 |
0.0050 |
| 404 |
HYPERLIPIDAEMIA |
60 |
0.0050 |
| 405 |
RESPIRATORY DISTRESS |
138 |
0.0050 |
| 406 |
C-REACTIVE PROTEIN ABNORMAL |
32 |
0.0050 |
| 407 |
IRON DEFICIENCY ANAEMIA |
46 |
0.0050 |
| 408 |
LUNG INFILTRATION |
44 |
0.0050 |
| 409 |
VITAMIN D DECREASED |
42 |
0.0049 |
| 410 |
URINARY TRACT INFECTION |
829 |
0.0049 |
| 411 |
HEPATIC ENCEPHALOPATHY |
45 |
0.0048 |
| 412 |
DUODENAL ULCER |
34 |
0.0048 |
| 413 |
HAEMORRHOIDS |
94 |
0.0048 |
| 414 |
FAILURE TO THRIVE |
25 |
0.0048 |
| 415 |
HYPERAMMONAEMIA |
24 |
0.0048 |
| 416 |
HYPERGLYCAEMIA |
173 |
0.0047 |
| 417 |
EXERCISE TOLERANCE DECREASED |
27 |
0.0047 |
| 418 |
RENAL DISORDER |
218 |
0.0047 |
| 419 |
ENTEROCOLITIS |
27 |
0.0047 |
| 420 |
NECROSIS |
26 |
0.0047 |
| 421 |
HAEMOGLOBIN ABNORMAL |
30 |
0.0047 |
| 422 |
GANGRENE |
28 |
0.0046 |
| 423 |
BLOOD MAGNESIUM DECREASED |
40 |
0.0046 |
| 424 |
PRE-ECLAMPSIA |
22 |
0.0046 |
| 425 |
ABDOMINAL HERNIA |
21 |
0.0046 |
| 426 |
PULMONARY FIBROSIS |
88 |
0.0046 |
| 427 |
OSTEOMYELITIS |
83 |
0.0046 |
| 428 |
OESOPHAGITIS |
50 |
0.0046 |
| 429 |
CLOSTRIDIUM DIFFICILE INFECTION |
99 |
0.0045 |
| 430 |
HAEMOLYSIS |
35 |
0.0045 |
| 431 |
DIABETES MELLITUS |
345 |
0.0045 |
| 432 |
COLITIS |
171 |
0.0045 |
| 433 |
GASTROINTESTINAL DISORDER |
404 |
0.0045 |
| 434 |
RENAL FAILURE |
598 |
0.0045 |
| 435 |
CHRONIC KIDNEY DISEASE |
342 |
0.0045 |
| 436 |
FUNGAL INFECTION |
150 |
0.0045 |
| 437 |
CHOLESTASIS |
86 |
0.0045 |
| 438 |
HEPATITIS C |
54 |
0.0045 |
| 439 |
BREATH SOUNDS ABNORMAL |
22 |
0.0045 |
| 440 |
SWELLING OF EYELID |
28 |
0.0045 |
| 441 |
SHOCK |
102 |
0.0044 |
| 442 |
KIDNEY INFECTION |
87 |
0.0044 |
| 443 |
STAPHYLOCOCCAL INFECTION |
146 |
0.0044 |
| 444 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
242 |
0.0044 |
| 445 |
CORONARY ARTERY STENOSIS |
22 |
0.0044 |
| 446 |
DISSEMINATED INTRAVASCULAR COAGULATION |
61 |
0.0043 |
| 447 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
32 |
0.0043 |
| 448 |
HAEMOGLOBIN DECREASED |
444 |
0.0043 |
| 449 |
DIALYSIS |
61 |
0.0043 |
| 450 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
38 |
0.0043 |
| 451 |
VIRAL INFECTION |
143 |
0.0043 |
| 452 |
CARDIO-RESPIRATORY ARREST |
178 |
0.0043 |
| 453 |
INTERSTITIAL LUNG DISEASE |
205 |
0.0042 |
| 454 |
VASCULITIS |
49 |
0.0042 |
| 455 |
INFLAMMATORY BOWEL DISEASE |
41 |
0.0042 |
| 456 |
SKIN LESION |
114 |
0.0042 |
| 457 |
HEPATITIS B |
25 |
0.0041 |
| 458 |
NEUTROPENIA |
559 |
0.0041 |
| 459 |
SPINAL OSTEOARTHRITIS |
36 |
0.0041 |
| 460 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
42 |
0.0041 |
| 461 |
HYPOXIA |
142 |
0.0040 |
| 462 |
PYREXIA |
1362 |
0.0039 |
| 463 |
ANGIOPATHY |
22 |
0.0039 |
| 464 |
PRODUCT USE IN UNAPPROVED INDICATION |
972 |
0.0039 |
| 465 |
PNEUMOTHORAX |
62 |
0.0039 |
| 466 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
34 |
0.0039 |
| 467 |
MALIGNANT MELANOMA |
52 |
0.0039 |
| 468 |
PLEURISY |
23 |
0.0039 |
| 469 |
THERAPY CHANGE |
38 |
0.0039 |
| 470 |
DIVERTICULITIS |
107 |
0.0039 |
| 471 |
ANAEMIA |
735 |
0.0038 |
| 472 |
SKIN INFECTION |
43 |
0.0038 |
| 473 |
ABNORMAL LOSS OF WEIGHT |
26 |
0.0038 |
| 474 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
26 |
0.0038 |
| 475 |
BRAIN OEDEMA |
48 |
0.0038 |
| 476 |
PLEURAL EFFUSION |
231 |
0.0038 |
| 477 |
PANCREATITIS ACUTE |
85 |
0.0038 |
| 478 |
MULTI-ORGAN FAILURE |
65 |
0.0038 |
| 479 |
MALNUTRITION |
42 |
0.0038 |
| 480 |
SMALL INTESTINAL OBSTRUCTION |
46 |
0.0037 |
| 481 |
FLUID OVERLOAD |
54 |
0.0037 |
| 482 |
PEMPHIGUS |
46 |
0.0037 |
| 483 |
PERICARDIAL EFFUSION |
85 |
0.0037 |
| 484 |
ENDOPHTHALMITIS |
22 |
0.0037 |
| 485 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
58 |
0.0037 |
| 486 |
ACUTE HEPATIC FAILURE |
50 |
0.0037 |
| 487 |
TACHYCARDIA |
325 |
0.0037 |
| 488 |
HEPATIC STEATOSIS |
68 |
0.0036 |
| 489 |
BONE MARROW FAILURE |
74 |
0.0036 |
| 490 |
FLANK PAIN |
34 |
0.0036 |
| 491 |
ISCHAEMIC STROKE |
64 |
0.0036 |
| 492 |
EYE PAIN |
202 |
0.0036 |
| 493 |
PULMONARY HYPERTENSION |
74 |
0.0035 |
| 494 |
METASTASES TO LUNG |
41 |
0.0035 |
| 495 |
ILEUS |
44 |
0.0035 |
| 496 |
THERAPY NON-RESPONDER |
159 |
0.0035 |
| 497 |
GASTRITIS |
93 |
0.0035 |
| 498 |
TACHYPNOEA |
48 |
0.0035 |
| 499 |
PNEUMONITIS |
96 |
0.0035 |
| 500 |
HAEMATOMA |
91 |
0.0035 |
| 501 |
LOW DENSITY LIPOPROTEIN INCREASED |
27 |
0.0035 |
| 502 |
MENTAL STATUS CHANGES |
96 |
0.0035 |
| 503 |
FAECES SOFT |
25 |
0.0034 |
| 504 |
INFECTION |
496 |
0.0034 |
| 505 |
BLOOD URINE PRESENT |
65 |
0.0034 |
| 506 |
TINNITUS |
157 |
0.0034 |
| 507 |
BLOOD PRESSURE FLUCTUATION |
82 |
0.0034 |
| 508 |
THROMBOCYTOPENIA |
380 |
0.0034 |
| 509 |
PREMATURE DELIVERY |
54 |
0.0034 |
| 510 |
OFF LABEL USE |
2957 |
0.0034 |
| 511 |
BLOOD DISORDER |
27 |
0.0034 |
| 512 |
DYSURIA |
124 |
0.0034 |
| 513 |
GASTRIC ULCER |
64 |
0.0034 |
| 514 |
HERPES ZOSTER |
193 |
0.0034 |
| 515 |
CHILLS |
391 |
0.0033 |
| 516 |
RENAL FAILURE ACUTE |
141 |
0.0033 |
| 517 |
PERITONITIS |
68 |
0.0033 |
| 518 |
TOXICITY TO VARIOUS AGENTS |
553 |
0.0033 |
| 519 |
MITRAL VALVE INCOMPETENCE |
37 |
0.0033 |
| 520 |
MUCOSAL INFLAMMATION |
85 |
0.0032 |
| 521 |
DIVERTICULUM |
23 |
0.0032 |
| 522 |
PRODUCT PRESCRIBING ERROR |
77 |
0.0032 |
| 523 |
WHITE BLOOD CELL COUNT INCREASED |
124 |
0.0032 |
| 524 |
RESPIRATORY TRACT INFECTION |
84 |
0.0032 |
| 525 |
UPPER RESPIRATORY TRACT INFECTION |
149 |
0.0032 |
| 526 |
RED BLOOD CELL COUNT DECREASED |
92 |
0.0032 |
| 527 |
LUNG DISORDER |
157 |
0.0032 |
| 528 |
GENERALISED TONIC-CLONIC SEIZURE |
53 |
0.0032 |
| 529 |
REBOUND EFFECT |
36 |
0.0032 |
| 530 |
VITAMIN D DEFICIENCY |
31 |
0.0032 |
| 531 |
DIARRHOEA |
2043 |
0.0032 |
| 532 |
TRANSAMINASES INCREASED |
70 |
0.0031 |
| 533 |
HYPERTHERMIA |
24 |
0.0031 |
| 534 |
MYOCARDITIS |
36 |
0.0031 |
| 535 |
ABSCESS |
50 |
0.0031 |
| 536 |
HYPERTENSION |
663 |
0.0031 |
| 537 |
HEPATIC FAILURE |
94 |
0.0031 |
| 538 |
ORAL CANDIDIASIS |
41 |
0.0031 |
| 539 |
SKIN CANCER |
67 |
0.0031 |
| 540 |
DYSPNOEA EXERTIONAL |
117 |
0.0031 |
| 541 |
INFUSION SITE PAIN |
40 |
0.0031 |
| 542 |
DIARRHOEA HAEMORRHAGIC |
29 |
0.0031 |
| 543 |
PERICARDITIS |
52 |
0.0031 |
| 544 |
SKIN ULCER |
80 |
0.0031 |
| 545 |
APHTHOUS ULCER |
24 |
0.0031 |
| 546 |
PNEUMONIA |
997 |
0.0031 |
| 547 |
HEMIPARESIS |
52 |
0.0031 |
| 548 |
DRUG INTOLERANCE |
296 |
0.0031 |
| 549 |
HEPATOTOXICITY |
68 |
0.0031 |
| 550 |
OSTEOPENIA |
46 |
0.0030 |
| 551 |
RENAL PAIN |
32 |
0.0030 |
| 552 |
HYPERCHOLESTEROLAEMIA |
29 |
0.0030 |
| 553 |
COAGULOPATHY |
50 |
0.0030 |
| 554 |
PRODUCTIVE COUGH |
143 |
0.0030 |
| 555 |
TREATMENT FAILURE |
248 |
0.0030 |
| 556 |
DEVICE RELATED INFECTION |
46 |
0.0030 |
| 557 |
AUTOIMMUNE DISORDER |
29 |
0.0030 |
| 558 |
MUSCLE DISORDER |
24 |
0.0030 |
| 559 |
PNEUMONIA ASPIRATION |
74 |
0.0030 |
| 560 |
IMMUNE SYSTEM DISORDER |
39 |
0.0030 |
| 561 |
LIVER FUNCTION TEST ABNORMAL |
85 |
0.0029 |
| 562 |
QUALITY OF LIFE DECREASED |
39 |
0.0029 |
| 563 |
ABDOMINAL PAIN |
674 |
0.0029 |
| 564 |
THERAPY PARTIAL RESPONDER |
45 |
0.0029 |
| 565 |
PERITONITIS BACTERIAL |
29 |
0.0029 |
| 566 |
CARDIOGENIC SHOCK |
41 |
0.0029 |
| 567 |
HYPOCALCAEMIA |
54 |
0.0029 |
| 568 |
LIVER INJURY |
70 |
0.0028 |
| 569 |
OEDEMA PERIPHERAL |
347 |
0.0028 |
| 570 |
ULCER |
45 |
0.0028 |
| 571 |
DIABETES MELLITUS INADEQUATE CONTROL |
50 |
0.0028 |
| 572 |
HYPOKALAEMIA |
130 |
0.0028 |
| 573 |
OSTEOPOROSIS |
115 |
0.0028 |
| 574 |
APPENDICITIS |
26 |
0.0028 |
| 575 |
BLOOD PRESSURE INCREASED |
424 |
0.0028 |
| 576 |
BLOOD TRIGLYCERIDES INCREASED |
49 |
0.0028 |
| 577 |
SYNOVITIS |
50 |
0.0028 |
| 578 |
INFLAMMATION |
143 |
0.0028 |
| 579 |
INTESTINAL PERFORATION |
31 |
0.0028 |
| 580 |
BLOOD SODIUM DECREASED |
52 |
0.0028 |
| 581 |
FISTULA |
31 |
0.0028 |
| 582 |
BLOOD CALCIUM DECREASED |
31 |
0.0028 |
| 583 |
TREATMENT NONCOMPLIANCE |
150 |
0.0027 |
| 584 |
HAEMODIALYSIS |
23 |
0.0027 |
| 585 |
COUGH |
768 |
0.0027 |
| 586 |
SENSORY LOSS |
22 |
0.0027 |
| 587 |
DEHYDRATION |
364 |
0.0027 |
| 588 |
HAEMATOCRIT DECREASED |
54 |
0.0027 |
| 589 |
HYPERBILIRUBINAEMIA |
28 |
0.0027 |
| 590 |
PULMONARY OEDEMA |
121 |
0.0027 |
| 591 |
SCIATICA |
43 |
0.0027 |
| 592 |
BLOOD IRON DECREASED |
32 |
0.0027 |
| 593 |
OEDEMA |
145 |
0.0027 |
| 594 |
PHARYNGITIS |
33 |
0.0027 |
| 595 |
ACUTE CORONARY SYNDROME |
22 |
0.0027 |
| 596 |
HYPOTHYROIDISM |
84 |
0.0026 |
| 597 |
IMPAIRED HEALING |
86 |
0.0026 |
| 598 |
HYPOTONIA |
26 |
0.0026 |
| 599 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
76 |
0.0026 |
| 600 |
BLOOD BILIRUBIN INCREASED |
70 |
0.0026 |
| 601 |
FACIAL PARALYSIS |
22 |
0.0026 |
| 602 |
GASTROINTESTINAL INFECTION |
23 |
0.0026 |
| 603 |
DRUG-INDUCED LIVER INJURY |
80 |
0.0025 |
| 604 |
GASTROENTERITIS VIRAL |
46 |
0.0025 |
| 605 |
MATERNAL EXPOSURE DURING PREGNANCY |
227 |
0.0025 |
| 606 |
HAEMATOTOXICITY |
24 |
0.0025 |
| 607 |
CHOLECYSTITIS |
30 |
0.0025 |
| 608 |
BLOOD CALCIUM INCREASED |
22 |
0.0025 |
| 609 |
CARDIAC ARREST |
207 |
0.0025 |
| 610 |
SUPRAVENTRICULAR TACHYCARDIA |
24 |
0.0025 |
| 611 |
HYPONATRAEMIA |
141 |
0.0025 |
| 612 |
FLUID RETENTION |
127 |
0.0025 |
| 613 |
CEREBRAL INFARCTION |
61 |
0.0025 |
| 614 |
TENDERNESS |
26 |
0.0025 |
| 615 |
PURPURA |
22 |
0.0025 |
| 616 |
IMMUNODEFICIENCY |
37 |
0.0025 |
| 617 |
FEBRILE NEUTROPENIA |
163 |
0.0025 |
| 618 |
HEPATIC CIRRHOSIS |
46 |
0.0024 |
| 619 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
54 |
0.0024 |
| 620 |
UVEITIS |
33 |
0.0024 |
| 621 |
ABDOMINAL PAIN LOWER |
61 |
0.0024 |
| 622 |
HIDRADENITIS |
22 |
0.0024 |
| 623 |
HAEMOPTYSIS |
67 |
0.0024 |
| 624 |
SECRETION DISCHARGE |
30 |
0.0024 |
| 625 |
METASTASES TO LIVER |
42 |
0.0024 |
| 626 |
HERNIA |
46 |
0.0024 |
| 627 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
60 |
0.0024 |
| 628 |
APHONIA |
33 |
0.0024 |
| 629 |
BLOOD PRESSURE SYSTOLIC INCREASED |
46 |
0.0024 |
| 630 |
ORAL HERPES |
46 |
0.0024 |
| 631 |
THERAPY INTERRUPTED |
168 |
0.0023 |
| 632 |
SARS-COV-2 TEST POSITIVE |
31 |
0.0023 |
| 633 |
CONDITION AGGRAVATED |
711 |
0.0023 |
| 634 |
CELLULITIS |
117 |
0.0023 |
| 635 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
39 |
0.0023 |
| 636 |
CATARACT |
138 |
0.0023 |
| 637 |
LACTIC ACIDOSIS |
75 |
0.0023 |
| 638 |
SPLENOMEGALY |
27 |
0.0023 |
| 639 |
GASTROOESOPHAGEAL REFLUX DISEASE |
184 |
0.0023 |
| 640 |
ASPIRATION |
25 |
0.0023 |
| 641 |
INTERNAL HAEMORRHAGE |
26 |
0.0023 |
| 642 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
39 |
0.0023 |
| 643 |
SYNCOPE |
227 |
0.0023 |
| 644 |
CENTRAL NERVOUS SYSTEM LESION |
31 |
0.0023 |
| 645 |
INFLUENZA |
249 |
0.0022 |
| 646 |
GLAUCOMA |
43 |
0.0022 |
| 647 |
LYMPHADENOPATHY |
79 |
0.0022 |
| 648 |
ADRENAL INSUFFICIENCY |
27 |
0.0022 |
| 649 |
ABORTION SPONTANEOUS |
89 |
0.0022 |
| 650 |
MYALGIA |
377 |
0.0022 |
| 651 |
URINARY RETENTION |
73 |
0.0022 |
| 652 |
OXYGEN SATURATION DECREASED |
122 |
0.0022 |
| 653 |
ATRIAL FIBRILLATION |
210 |
0.0022 |
| 654 |
RENAL INJURY |
64 |
0.0022 |
| 655 |
POST PROCEDURAL COMPLICATION |
41 |
0.0021 |
| 656 |
DISEASE PROGRESSION |
252 |
0.0021 |
| 657 |
VOMITING |
1001 |
0.0021 |
| 658 |
HYPOPHAGIA |
54 |
0.0021 |
| 659 |
PRODUCT PRESCRIBING ISSUE |
46 |
0.0021 |
| 660 |
HEPATITIS |
54 |
0.0021 |
| 661 |
PARALYSIS |
30 |
0.0021 |
| 662 |
ABDOMINAL PAIN UPPER |
431 |
0.0021 |
| 663 |
TREMOR |
345 |
0.0021 |
| 664 |
LABORATORY TEST ABNORMAL |
61 |
0.0021 |
| 665 |
DECREASED APPETITE |
479 |
0.0021 |
| 666 |
ALANINE AMINOTRANSFERASE INCREASED |
126 |
0.0021 |
| 667 |
HEPATOCELLULAR INJURY |
29 |
0.0020 |
| 668 |
CYTOKINE RELEASE SYNDROME |
41 |
0.0020 |
| 669 |
DIABETIC KETOACIDOSIS |
49 |
0.0020 |
| 670 |
HEPATIC CYTOLYSIS |
26 |
0.0020 |
| 671 |
ABDOMINAL DISCOMFORT |
340 |
0.0020 |
| 672 |
LOCALISED INFECTION |
49 |
0.0020 |
| 673 |
INTENTIONAL PRODUCT USE ISSUE |
175 |
0.0020 |
| 674 |
WHITE BLOOD CELL COUNT DECREASED |
216 |
0.0020 |
| 675 |
DELIRIUM |
69 |
0.0020 |
| 676 |
RESTLESS LEGS SYNDROME |
36 |
0.0020 |
| 677 |
WEIGHT DECREASED |
551 |
0.0020 |
| 678 |
HEPATIC ENZYME INCREASED |
134 |
0.0020 |
| 679 |
BLOOD GLUCOSE ABNORMAL |
36 |
0.0019 |
| 680 |
CYSTITIS |
62 |
0.0019 |
| 681 |
ASTHENIA |
726 |
0.0019 |
| 682 |
HIATUS HERNIA |
25 |
0.0019 |
| 683 |
GENERAL PHYSICAL HEALTH DETERIORATION |
223 |
0.0019 |
| 684 |
BLOOD TEST ABNORMAL |
27 |
0.0019 |
| 685 |
WRIST FRACTURE |
23 |
0.0019 |
| 686 |
MYELOSUPPRESSION |
69 |
0.0019 |
| 687 |
VISION BLURRED |
263 |
0.0019 |
| 688 |
BLINDNESS UNILATERAL |
27 |
0.0019 |
| 689 |
NEOPLASM |
22 |
0.0019 |
| 690 |
RESPIRATORY DISORDER |
57 |
0.0019 |
| 691 |
JAUNDICE |
51 |
0.0019 |
| 692 |
EOSINOPHILIA |
33 |
0.0019 |
| 693 |
LYMPHOMA |
29 |
0.0019 |
| 694 |
PANCREATITIS |
99 |
0.0019 |
| 695 |
LIVER DISORDER |
83 |
0.0019 |
| 696 |
ABDOMINAL DISTENSION |
195 |
0.0019 |
| 697 |
HOSPITALISATION |
286 |
0.0019 |
| 698 |
OSTEONECROSIS |
61 |
0.0019 |
| 699 |
BLOOD CHOLESTEROL INCREASED |
86 |
0.0018 |
| 700 |
THROMBOSIS |
148 |
0.0018 |
| 701 |
PROCEDURAL PAIN |
51 |
0.0018 |
| 702 |
ORTHOSTATIC HYPOTENSION |
32 |
0.0018 |
| 703 |
CARDIAC FAILURE |
147 |
0.0018 |
| 704 |
HYPOTENSION |
367 |
0.0018 |
| 705 |
LOWER LIMB FRACTURE |
35 |
0.0018 |
| 706 |
DEEP VEIN THROMBOSIS |
118 |
0.0018 |
| 707 |
NIGHT SWEATS |
58 |
0.0018 |
| 708 |
GASTROINTESTINAL HAEMORRHAGE |
150 |
0.0018 |
| 709 |
JOINT RANGE OF MOTION DECREASED |
24 |
0.0018 |
| 710 |
TENDON RUPTURE |
22 |
0.0018 |
| 711 |
ATAXIA |
21 |
0.0018 |
| 712 |
HEPATIC FUNCTION ABNORMAL |
66 |
0.0018 |
| 713 |
DERMATITIS |
37 |
0.0018 |
| 714 |
BODY TEMPERATURE INCREASED |
36 |
0.0018 |
| 715 |
IMPAIRED GASTRIC EMPTYING |
24 |
0.0018 |
| 716 |
LIMB DISCOMFORT |
54 |
0.0017 |
| 717 |
MALAISE |
758 |
0.0017 |
| 718 |
HYPERTHYROIDISM |
25 |
0.0017 |
| 719 |
INTESTINAL OBSTRUCTION |
65 |
0.0017 |
| 720 |
PERIPHERAL SWELLING |
264 |
0.0017 |
| 721 |
DYSPNOEA |
965 |
0.0017 |
| 722 |
INSURANCE ISSUE |
26 |
0.0017 |
| 723 |
SOMNOLENCE |
340 |
0.0017 |
| 724 |
FOOT FRACTURE |
32 |
0.0017 |
| 725 |
PULMONARY EMBOLISM |
160 |
0.0017 |
| 726 |
DEATH |
1450 |
0.0017 |
| 727 |
BRADYCARDIA |
89 |
0.0017 |
| 728 |
SURGERY |
98 |
0.0017 |
| 729 |
MYELODYSPLASTIC SYNDROME |
24 |
0.0017 |
| 730 |
PULMONARY ARTERIAL HYPERTENSION |
24 |
0.0017 |
| 731 |
APHASIA |
50 |
0.0017 |
| 732 |
PRESCRIBED UNDERDOSE |
33 |
0.0017 |
| 733 |
HYPOACUSIS |
70 |
0.0016 |
| 734 |
SEASONAL ALLERGY |
23 |
0.0016 |
| 735 |
ILLNESS |
167 |
0.0016 |
| 736 |
LIMB INJURY |
44 |
0.0016 |
| 737 |
SKIN DISORDER |
54 |
0.0016 |
| 738 |
ANKLE FRACTURE |
25 |
0.0016 |
| 739 |
PLATELET COUNT DECREASED |
172 |
0.0016 |
| 740 |
PRODUCT USE ISSUE |
303 |
0.0016 |
| 741 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
40 |
0.0016 |
| 742 |
UPPER LIMB FRACTURE |
32 |
0.0016 |
| 743 |
BRAIN FOG |
25 |
0.0016 |
| 744 |
PSYCHOTIC DISORDER |
47 |
0.0016 |
| 745 |
SINUSITIS |
163 |
0.0016 |
| 746 |
METASTASES TO BONE |
26 |
0.0016 |
| 747 |
LOWER RESPIRATORY TRACT INFECTION |
72 |
0.0016 |
| 748 |
SWELLING |
148 |
0.0016 |
| 749 |
INTENTIONAL DOSE OMISSION |
45 |
0.0016 |
| 750 |
HEADACHE |
989 |
0.0016 |
| 751 |
NERVOUS SYSTEM DISORDER |
49 |
0.0016 |
| 752 |
DEAFNESS |
41 |
0.0016 |
| 753 |
NAUSEA |
1239 |
0.0016 |
| 754 |
HALLUCINATION, VISUAL |
33 |
0.0016 |
| 755 |
JOINT STIFFNESS |
41 |
0.0016 |
| 756 |
DYSPHAGIA |
148 |
0.0016 |
| 757 |
EYE DISORDER |
51 |
0.0015 |
| 758 |
SINUS TACHYCARDIA |
22 |
0.0015 |
| 759 |
MUSCULAR WEAKNESS |
176 |
0.0015 |
| 760 |
RHINORRHOEA |
100 |
0.0015 |
| 761 |
MELAENA |
34 |
0.0015 |
| 762 |
TYPE 2 DIABETES MELLITUS |
52 |
0.0015 |
| 763 |
NASOPHARYNGITIS |
284 |
0.0015 |
| 764 |
LIVER FUNCTION TEST INCREASED |
33 |
0.0015 |
| 765 |
CEREBRAL HAEMORRHAGE |
55 |
0.0015 |
| 766 |
ANGINA PECTORIS |
44 |
0.0015 |
| 767 |
RASH MACULO-PAPULAR |
34 |
0.0015 |
| 768 |
PREMATURE BABY |
46 |
0.0015 |
| 769 |
BRONCHITIS |
113 |
0.0015 |
| 770 |
OROPHARYNGEAL PAIN |
141 |
0.0015 |
| 771 |
CONTRAINDICATED PRODUCT ADMINISTERED |
46 |
0.0015 |
| 772 |
CORONARY ARTERY DISEASE |
46 |
0.0015 |
| 773 |
OBESITY |
24 |
0.0015 |
| 774 |
ASPARTATE AMINOTRANSFERASE INCREASED |
80 |
0.0015 |
| 775 |
EPILEPSY |
46 |
0.0015 |
| 776 |
HIP ARTHROPLASTY |
23 |
0.0015 |
| 777 |
BLOOD POTASSIUM DECREASED |
45 |
0.0015 |
| 778 |
CHOLELITHIASIS |
49 |
0.0015 |
| 779 |
SWELLING FACE |
97 |
0.0015 |
| 780 |
CARDIOMYOPATHY |
22 |
0.0015 |
| 781 |
SKIN HAEMORRHAGE |
22 |
0.0015 |
| 782 |
CHEST DISCOMFORT |
152 |
0.0015 |
| 783 |
HAEMORRHAGE |
155 |
0.0015 |
| 784 |
DELUSION |
23 |
0.0015 |
| 785 |
NASAL CONGESTION |
87 |
0.0015 |
| 786 |
VISUAL IMPAIRMENT |
182 |
0.0015 |
| 787 |
WOUND |
41 |
0.0015 |
| 788 |
SCAR |
25 |
0.0015 |
| 789 |
VERTIGO |
89 |
0.0015 |
| 790 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
70 |
0.0015 |
| 791 |
FEAR |
39 |
0.0014 |
| 792 |
DRUG INEFFECTIVE |
1894 |
0.0014 |
| 793 |
UNRESPONSIVE TO STIMULI |
37 |
0.0014 |
| 794 |
HAEMATOCHEZIA |
78 |
0.0014 |
| 795 |
FALL |
469 |
0.0014 |
| 796 |
MANIA |
23 |
0.0014 |
| 797 |
NEPHROLITHIASIS |
64 |
0.0014 |
| 798 |
VENTRICULAR TACHYCARDIA |
23 |
0.0014 |
| 799 |
PHOTOSENSITIVITY REACTION |
23 |
0.0014 |
| 800 |
RHABDOMYOLYSIS |
58 |
0.0014 |
| 801 |
WEIGHT INCREASED |
311 |
0.0014 |
| 802 |
DISORIENTATION |
55 |
0.0014 |
| 803 |
FATIGUE |
1075 |
0.0014 |
| 804 |
THERAPEUTIC RESPONSE DECREASED |
83 |
0.0014 |
| 805 |
ARTHRALGIA |
569 |
0.0014 |
| 806 |
THERAPY CESSATION |
70 |
0.0014 |
| 807 |
BLOOD PRESSURE ABNORMAL |
27 |
0.0014 |
| 808 |
CEREBROVASCULAR ACCIDENT |
225 |
0.0013 |
| 809 |
BLOOD PRESSURE DECREASED |
88 |
0.0013 |
| 810 |
DYSPEPSIA |
130 |
0.0013 |
| 811 |
HEART RATE INCREASED |
130 |
0.0013 |
| 812 |
AMENORRHOEA |
23 |
0.0013 |
| 813 |
BLOOD GLUCOSE INCREASED |
247 |
0.0013 |
| 814 |
NEUROPATHY PERIPHERAL |
123 |
0.0013 |
| 815 |
ACUTE MYOCARDIAL INFARCTION |
38 |
0.0013 |
| 816 |
CHEST PAIN |
238 |
0.0013 |
| 817 |
TRANSIENT ISCHAEMIC ATTACK |
43 |
0.0013 |
| 818 |
THROAT IRRITATION |
57 |
0.0013 |
| 819 |
INSOMNIA |
334 |
0.0013 |
| 820 |
INFUSION RELATED REACTION |
83 |
0.0013 |
| 821 |
CONFUSIONAL STATE |
201 |
0.0012 |
| 822 |
SPEECH DISORDER |
65 |
0.0012 |
| 823 |
EAR INFECTION |
33 |
0.0012 |
| 824 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
88 |
0.0012 |
| 825 |
PAIN IN JAW |
35 |
0.0012 |
| 826 |
GAIT INABILITY |
41 |
0.0012 |
| 827 |
ANHEDONIA |
32 |
0.0012 |
| 828 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
35 |
0.0012 |
| 829 |
DYSPHONIA |
71 |
0.0012 |
| 830 |
RASH ERYTHEMATOUS |
58 |
0.0012 |
| 831 |
SEIZURE |
139 |
0.0012 |
| 832 |
EPISTAXIS |
90 |
0.0012 |
| 833 |
PRODUCT DOSE OMISSION IN ERROR |
34 |
0.0012 |
| 834 |
POLLAKIURIA |
50 |
0.0012 |
| 835 |
NEOPLASM MALIGNANT |
80 |
0.0012 |
| 836 |
SPINAL FRACTURE |
24 |
0.0012 |
| 837 |
CARDIAC DISORDER |
112 |
0.0012 |
| 838 |
DIZZINESS |
596 |
0.0012 |
| 839 |
PRESCRIBED OVERDOSE |
23 |
0.0012 |
| 840 |
COLITIS ULCERATIVE |
53 |
0.0012 |
| 841 |
MUSCULOSKELETAL PAIN |
62 |
0.0012 |
| 842 |
PSORIATIC ARTHROPATHY |
48 |
0.0012 |
| 843 |
ARTHRITIS |
93 |
0.0012 |
| 844 |
NO ADVERSE EVENT |
213 |
0.0012 |
| 845 |
RESTLESSNESS |
43 |
0.0012 |
| 846 |
EXPOSURE DURING PREGNANCY |
73 |
0.0012 |
| 847 |
JOINT INJURY |
25 |
0.0012 |
| 848 |
RASH PAPULAR |
26 |
0.0012 |
| 849 |
URINARY INCONTINENCE |
34 |
0.0011 |
| 850 |
LETHARGY |
66 |
0.0011 |
| 851 |
JOINT SWELLING |
138 |
0.0011 |
| 852 |
PRODUCT AVAILABILITY ISSUE |
26 |
0.0011 |
| 853 |
MOBILITY DECREASED |
82 |
0.0011 |
| 854 |
STOMATITIS |
69 |
0.0011 |
| 855 |
GASTRIC DISORDER |
39 |
0.0011 |
| 856 |
ANGIOEDEMA |
50 |
0.0011 |
| 857 |
INTERNATIONAL NORMALISED RATIO INCREASED |
32 |
0.0011 |
| 858 |
WHEEZING |
66 |
0.0011 |
| 859 |
BACK PAIN |
258 |
0.0011 |
| 860 |
FAECES DISCOLOURED |
24 |
0.0011 |
| 861 |
HEAD INJURY |
35 |
0.0011 |
| 862 |
PRODUCT DISPENSING ERROR |
24 |
0.0011 |
| 863 |
LOSS OF CONSCIOUSNESS |
139 |
0.0011 |
| 864 |
PRODUCT DOSE OMISSION ISSUE |
318 |
0.0011 |
| 865 |
HYPOGLYCAEMIA |
52 |
0.0011 |
| 866 |
RIB FRACTURE |
22 |
0.0011 |
| 867 |
NEURALGIA |
26 |
0.0011 |
| 868 |
CHROMATURIA |
24 |
0.0011 |
| 869 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
42 |
0.0011 |
| 870 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
27 |
0.0010 |
| 871 |
RECTAL HAEMORRHAGE |
45 |
0.0010 |
| 872 |
CARDIAC FAILURE CONGESTIVE |
84 |
0.0010 |
| 873 |
GAIT DISTURBANCE |
200 |
0.0010 |
| 874 |
ILL-DEFINED DISORDER |
63 |
0.0010 |
| 875 |
FREQUENT BOWEL MOVEMENTS |
28 |
0.0010 |
| 876 |
SLEEP DISORDER |
73 |
0.0010 |
| 877 |
DISCOMFORT |
63 |
0.0010 |
| 878 |
DYSSTASIA |
30 |
0.0010 |
| 879 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
46 |
0.0010 |
| 880 |
IRRITABLE BOWEL SYNDROME |
22 |
0.0010 |
| 881 |
BLISTER |
57 |
0.0010 |
| 882 |
MEMORY IMPAIRMENT |
139 |
0.0010 |
| 883 |
DYSARTHRIA |
38 |
0.0010 |
| 884 |
MIGRAINE |
96 |
0.0010 |
| 885 |
PRURITUS |
386 |
0.0010 |
| 886 |
AMNESIA |
65 |
0.0010 |
| 887 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
180 |
0.0010 |
| 888 |
LUNG NEOPLASM MALIGNANT |
41 |
0.0010 |
| 889 |
HEART RATE DECREASED |
35 |
0.0010 |
| 890 |
PAIN IN EXTREMITY |
293 |
0.0010 |
| 891 |
OSTEOARTHRITIS |
42 |
0.0010 |
| 892 |
EATING DISORDER |
21 |
0.0010 |
| 893 |
MUSCULOSKELETAL STIFFNESS |
85 |
0.0010 |
| 894 |
CONSTIPATION |
211 |
0.0010 |
| 895 |
HIP FRACTURE |
31 |
0.0010 |
| 896 |
VISUAL ACUITY REDUCED |
32 |
0.0010 |
| 897 |
ALOPECIA |
189 |
0.0010 |
| 898 |
ACCIDENTAL OVERDOSE |
35 |
0.0010 |
| 899 |
FLATULENCE |
54 |
0.0010 |
| 900 |
MENTAL IMPAIRMENT |
23 |
0.0009 |
| 901 |
ANAPHYLACTIC REACTION |
52 |
0.0009 |
| 902 |
ARTHROPATHY |
52 |
0.0009 |
| 903 |
ARRHYTHMIA |
43 |
0.0009 |
| 904 |
PALPITATIONS |
106 |
0.0009 |
| 905 |
FIBROMYALGIA |
22 |
0.0009 |
| 906 |
MOVEMENT DISORDER |
29 |
0.0009 |
| 907 |
PARAESTHESIA |
141 |
0.0009 |
| 908 |
SKIN DISCOLOURATION |
41 |
0.0009 |
| 909 |
MYOCARDIAL INFARCTION |
153 |
0.0009 |
| 910 |
HYPOAESTHESIA |
131 |
0.0009 |
| 911 |
ADVERSE DRUG REACTION |
78 |
0.0009 |
| 912 |
CARDIOVASCULAR DISORDER |
22 |
0.0009 |
| 913 |
DEMENTIA |
24 |
0.0009 |
| 914 |
DRY MOUTH |
69 |
0.0008 |
| 915 |
MENTAL DISORDER |
37 |
0.0008 |
| 916 |
RASH |
369 |
0.0008 |
| 917 |
CONTUSION |
81 |
0.0008 |
| 918 |
NECK PAIN |
47 |
0.0008 |
| 919 |
FEMUR FRACTURE |
26 |
0.0008 |
| 920 |
BLOOD GLUCOSE DECREASED |
40 |
0.0008 |
| 921 |
PAIN |
510 |
0.0008 |
| 922 |
FEELING ABNORMAL |
195 |
0.0008 |
| 923 |
UNDERDOSE |
59 |
0.0008 |
| 924 |
PRODUCT SUBSTITUTION ISSUE |
46 |
0.0008 |
| 925 |
ROAD TRAFFIC ACCIDENT |
33 |
0.0008 |
| 926 |
DEPRESSED MOOD |
41 |
0.0008 |
| 927 |
PANIC ATTACK |
28 |
0.0008 |
| 928 |
FEELING HOT |
47 |
0.0008 |
| 929 |
INCORRECT DOSE ADMINISTERED |
175 |
0.0008 |
| 930 |
HYPERSENSITIVITY |
139 |
0.0007 |
| 931 |
DISTURBANCE IN ATTENTION |
40 |
0.0007 |
| 932 |
INFLUENZA LIKE ILLNESS |
61 |
0.0007 |
| 933 |
RASH PRURITIC |
40 |
0.0007 |
| 934 |
BONE PAIN |
43 |
0.0007 |
| 935 |
COGNITIVE DISORDER |
34 |
0.0007 |
| 936 |
UNEVALUABLE EVENT |
55 |
0.0007 |
| 937 |
FOETAL EXPOSURE DURING PREGNANCY |
59 |
0.0007 |
| 938 |
RHEUMATOID ARTHRITIS |
82 |
0.0007 |
| 939 |
EXPIRED PRODUCT ADMINISTERED |
24 |
0.0007 |
| 940 |
THERAPEUTIC RESPONSE UNEXPECTED |
32 |
0.0007 |
| 941 |
MUSCLE SPASMS |
129 |
0.0007 |
| 942 |
BURNING SENSATION |
49 |
0.0007 |
| 943 |
INJURY |
49 |
0.0007 |
| 944 |
OVERDOSE |
150 |
0.0007 |
| 945 |
PLASMA CELL MYELOMA |
27 |
0.0007 |
| 946 |
MOOD SWINGS |
22 |
0.0007 |
| 947 |
EYE SWELLING |
25 |
0.0007 |
| 948 |
NERVOUSNESS |
35 |
0.0007 |
| 949 |
HALLUCINATION |
50 |
0.0007 |
| 950 |
BALANCE DISORDER |
57 |
0.0007 |
| 951 |
DEPRESSION |
149 |
0.0007 |
| 952 |
OCULAR HYPERAEMIA |
31 |
0.0007 |
| 953 |
DRY EYE |
32 |
0.0006 |
| 954 |
NEUTROPHIL COUNT DECREASED |
26 |
0.0006 |
| 955 |
RASH MACULAR |
22 |
0.0006 |
| 956 |
DERMATITIS ATOPIC |
33 |
0.0006 |
| 957 |
ERYTHEMA |
126 |
0.0006 |
| 958 |
CONVULSION |
34 |
0.0006 |
| 959 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
31 |
0.0006 |
| 960 |
ANXIETY |
166 |
0.0006 |
| 961 |
HYPERHIDROSIS |
74 |
0.0006 |
| 962 |
URTICARIA |
95 |
0.0006 |
| 963 |
ASTHMA |
64 |
0.0006 |
| 964 |
AGITATION |
40 |
0.0005 |
| 965 |
SUICIDE ATTEMPT |
32 |
0.0005 |
| 966 |
EYE IRRITATION |
29 |
0.0005 |
| 967 |
ACNE |
38 |
0.0005 |
| 968 |
DYSGEUSIA |
37 |
0.0005 |
| 969 |
IRRITABILITY |
29 |
0.0005 |
| 970 |
ECZEMA |
25 |
0.0005 |
| 971 |
ADVERSE EVENT |
44 |
0.0005 |
| 972 |
EMOTIONAL DISTRESS |
57 |
0.0005 |
| 973 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
33 |
0.0005 |
| 974 |
PSORIASIS |
59 |
0.0005 |
| 975 |
SUICIDAL IDEATION |
41 |
0.0004 |
| 976 |
AGGRESSION |
22 |
0.0004 |
| 977 |
HOT FLUSH |
32 |
0.0004 |
| 978 |
DRY SKIN |
56 |
0.0004 |
| 979 |
FLUSHING |
41 |
0.0004 |
| 980 |
SKIN EXFOLIATION |
34 |
0.0004 |
| 981 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
79 |
0.0004 |
| 982 |
INTENTIONAL PRODUCT MISUSE |
32 |
0.0004 |
| 983 |
INJECTION SITE BRUISING |
27 |
0.0003 |
| 984 |
INJECTION SITE HAEMORRHAGE |
26 |
0.0003 |
| 985 |
PRODUCT STORAGE ERROR |
27 |
0.0003 |
| 986 |
DEVICE ISSUE |
23 |
0.0003 |
| 987 |
MALIGNANT NEOPLASM PROGRESSION |
26 |
0.0003 |
| 988 |
BREAST CANCER |
23 |
0.0002 |
| 989 |
DRUG DOSE OMISSION |
37 |
0.0002 |
| 990 |
INJECTION SITE PAIN |
66 |
0.0002 |
| 991 |
ACCIDENTAL EXPOSURE TO PRODUCT |
21 |
0.0002 |
| 992 |
PRODUCT QUALITY ISSUE |
23 |
0.0002 |